Finny logo
Finny logo
Dibs:
Dibs:
0

Array BioPharma (ARRY) earnings: expect -22% revenue decline

5:27 pm ET, 06 May 2019

Array BioPharma Inc. (ARRY) is announcing earnings on May 08. Wondering what revenue and earnings will look like?

What should you expect from the upcoming earnings?

Revenue for the next quarter is expected to be $52M, which implies -22% growth rate year-over-year.

Earnings per share are expected to come in at $-0.21. If this materializes, EPS will decline -91% year-over-year.

How did the stock do last month?

Over the last month, Array BioPharma Inc. (ARRY) returned -1.19%.

What do analysts say about the stock?

Array BioPharma Inc. (ARRY) average analyst price target is 23.08% above its current price ($22.75).

For the latest price and information on Array BioPharma Inc., please visit Finstead and ask for "ARRY", "ARRY analysis" or "ARRY news".

Array BioPharma Inc. (ARRY) Stock Guide

Updated at: 6:18 pm ET, 16 Sep 2020

Before we start: if you're looking for ARRY stock price, you can quickly find it out by visiting Finny and typing "ARRY quote". If you're looking for a quick scoop on ARRY stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "ARRY". You'll get all this info in one place. Or you can just type "ARRY news" to get the latest stock news.

Looking to buy or sell Array BioPharma Inc. (ARRY)? Interested in getting the full scoop on ARRY, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this ARRY stock guide, we'll address key questions about ARRY, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. ARRY buy or sell? What is ARRY Finny Score?
2. What are the reasons to buy ARRY? Why should I buy ARRY stock?
3. What are the reasons to sell ARRY? Why should I sell ARRY stock?
4. What are ARRY key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Analysis

1. ARRY buy or sell? What is ARRY Finny Score?

#{finnyScore:null}Our quantitative analysis shows 0 reasons to buy and 2 reasons to sell ARRY. ARRY doesn’t have an assigned Finny Score, because we don’t have sufficient data points to score the stock.

2. What are the reasons to buy ARRY? Why should I buy ARRY stock?

We can’t think of any good reason to buy this stock, which doesn’t mean they don’t exist.

3. What are the reasons to sell ARRY? Why should I sell ARRY stock?

Let's look at the reasons to sell ARRY stock (i.e., the bear case):

  • ARRY stock price ($47.85) is close to the 52-week high ($47.96). Perhaps now is a good time to sell? See ARRY price chart.
  • ARRY profitability is declining. The YoY profit margin change was -81.32 percentage points. See ARRY profitability chart.

Key Stats

4. What are ARRY key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for ARRY:

Metrics ARRY
Price $37.49
Average Price Target / Upside N/A
Average Analyst Rating N/A
Forward Dividend Yield 0.00%
Industry Biotechnology
Sector Healthcare
Number of Employees 298
Market Cap N/A
Forward P/E Ratio N/A
Price/Book Ratio N/A
Revenue (TTM) $975.12M
YoY Quarterly Revenue Growth 145.20%
Profit Margin 12.41%

If you liked this analysis, check out Stock Guides for other stocks.

Follow Us